Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Singh, Sonia
- Influence of Different Grades of Knee Osteoarthritis on Foot Posture
Abstract Views :914 |
PDF Views:0
Authors
Affiliations
1 College of Physiotherapy, Adesh University, Bathinda, IN
2 Department of Physiotherapy, Punjabi University, Patiala, IN
1 College of Physiotherapy, Adesh University, Bathinda, IN
2 Department of Physiotherapy, Punjabi University, Patiala, IN
Source
Indian Journal of Physiotherapy & Occupational Therapy-An International Journal, Vol 8, No 1 (2014), Pagination: 14-18Abstract
Knee osteoarthritis (OA) is one of the major causes of pain and physical disability. The assessment and treatment of knee osteoarthritis is mostly localized to knee, however compensatory biomechanical changes occurring at knee are also altering foot posture which is further influencing the progression of OA. So the present study has been designed to investigate the relationship between different grades of knee osteoarthritis and foot posture. In the present study 40 patients (80 knees) were taken and divided into four groups according to Kellgen and Lawrence Scale on the basis of radiographs. The foot posture was assessed using the foot posture index (FPI-6). Coefficient of correlation was used to investigate the relationship between grades of knee OA and foot posture. ANOVA was used for comparison of foot posture index scores among the different grades. Further analysis was done using Tukey HSD post hoc test. Findings of the study suggested a significant positive correlation between grades of Knee Osteoarthritis and foot posture index (r=0.84, p< 0.0001). The study concluded that Grade 3 and Grade 4 of Knee Osteoarthritis exhibits either a pronated or highly pronated foot, while near normal foot was observed in grade 1 and 2. Thus compensatory foot changes are more prominent in grade 3 and 4 of OA.Keywords
Osteoarthritis, Foot Posture Index
References
- Felson DT, Naimark A, Anderson J, Kazis L,Castelli W, Meenan RF. The prevalence of kneeosteoarthritis in the elderly: the FraminghamOsteoarthritis Study. Arthritis and Rheumatism. 1987; 30: 914–918.
- Fife RS, Klippel JH, Weyand CM, Wortmann RL.Osteoarthritis: Epidemiology, pathology andpathogenesis. Arthritis and Rheumatism. 1997;216–217.
- Peyron JG, Altman RD, Moskowitz RW, HoweDS, Goldberg VM, Mankin HJ. Osteoarthritis:diagnosis and medical surgical management. Theepidemiology of osteoarthritis. In (eds.)Moskowitz RW, Howe DS, Goldberg VM,Mankin HJ. Philadelphia: WB Saunders. 1993;15–35.
- Weissmann N Barbara. Imaging of degenerativeand traumatic conditions. First edition. MobsyElsevier; 2009; 107.
- Doherty M, Lanyon P, Rolston SH. Musculoskeletal disorders. Davidson’s Principlesand practice of medicine. In (eds). Boon NA,Colledge NR, Walker BR. 20th edition. Edinburgh, Churchill Livingstone. 2006;1065-1144.
- Oliveria SA, Felson DT, Reed JI, Cirillo PA, WalkerAM. Incidence of symptomatic hand, hip, andknee osteoarthritis among patients in a healthmaintenance organization. Arthritis andRheumatism. 1995; 38: 1134–41.
- Mundermann A, Dyrby CO, Debra EH, SharmaL, and Thomas P. Andriacchi. Potential Strategiesto Reduce Medial Compartment Loading inPatients With Knee Osteoarthritis of VaryingSeverity Reduced Walking Speed. Journal ofArthritis and Rheumatism. 2004; 50(4):1172–1178.
- Sharma L, Hurwitz DE, Thonar EJ, Sum JA, LenzME, Dunlop DD. Knee adduction moment, serumhyaluronan level, and disease severity in medialtibiofemoral osteoarthritis. Arthritis andRheumatism. 1998; 41: 1233–40.
- Miyazaki T, Wada M, Kawahara H, Sato M, BabaH, Shimada S. Dynamic load at baseline canpredict radiographic disease progression inmedial compartment knee osteoarthritis. Annalsof Rheumatic Diseases. 2002; 61: 617–22.
- Schipplein OD, Andriacchi TP. Interactionbetween active and passive knee stabilizersduring level walking. Journal of OrthopedicResearch. 1991; 9:113–9.
- Van Gheluwe B, Kirby KA, Hagman F. Effects ofsimulated genu valgum and genu varum onground reaction forces and subtalar joint functionduring gait. Journal of American PodiatricMedical Association. 2005; 95: 531-541.
- Levinger P, Menz HB, Fotoohabaadi MR, FellerJA, Bartlett JR, Bergman NR. Foot Posture inpeople with medial compartment kneeosteoarthritis. Journal of foot and ankle research 2010; 3-29.
- Crenshaw SJ, Pollo FE, Calton EF: Effects oflateral-wedged insoles on kinetics at the knee. Clinical Orthopaedics and Related Research. 2002; 185-192.
- Shimada S, Kobayashi S, Wada M, Uchida K,Sasaki S, Kawahara H, Yayama T, Kitade I, KameiK, Kubota M, Baba H. Effects of disease severityon response to lateral wedged shoe insole formedial compartment knee osteoarthritis. Archives of physical medicine and rehabilitation. 2006; 87: 1436-1441.
- Hinman-Harvard RS, Payne C, Metcalf BR,Wrigley TV, Bennell KL: Lateral wedges in kneeosteoarthritis: What are their immediate clinicaland biomechanical effects and can these predicta three-month clinical outcome. Arthritis &Rheumatism. 2008; 59: 408-415.
- Kerrigan DC, Lelas JL, Goggins J, Merriman GJ,Kaplan RJ, Felson DT. Effectiveness of a lateralwedgeinsole on knee varus torque in patientswith knee osteoarthritis. Archives of physicalmedicine and rehabilitation. 2002; 83: 889-893.
- Rodrigues PT, Ferreira AF, Pereira RM, Bonfa E,Borba EF, Fuller R. Effectiveness of medial-wedgeinsole treatment for valgus knee osteoarthritis. Arthritis and Rheumatism. 2008; 59: 603-608.
- Kakihana W, Akai M, Nakazawa K, TakashimaT, Naito K, Torii S. Effects of laterally wedgedinsoles on knee and subtalar joint moments. Archives of physical medicine and rehabilitation. 2005; 86: 1465-1471.
- Barton J Christian , Levinger Pazit, Crossley MKay, Kate E Webster, Menz B Hylton. Relationships between the Foot Posture Indexand foot kinematics during gait in individualswith and without patellofemoral pain syndrome. Journal of Foot and Ankle Research. 2011, 4:10
- Cornwall MW, McPoil TG. Relation betweenstatic foot posture and foot mobility. Journal ofankle and foot research. 2011; 4:4.
- Burns J, Keenan AM, Redmond A. Foot type andoveruse injury in triathletes. Journal of AmericanPodiatric Medical Association. 2005; 95: 235-241.
- Cain LE, Nicholson LL, Adams RD, Burns J. Footmorphology and foot/ ankle injury in indoorfootball. Journal of Science Medicine and Sport. 2007; 10: 311-319.
- Nielsen RG, Rathleff M, Kersting UG, SimonsenO, Moelgaard C, Jensen K, Olesen GG, Lundbye-Christensen S, Kaalund S. The predictive valueof the foot posture index on dynamic function. Journal of Foot and Ankle Research. 2008; 1(1):37.
- Redmond AC, Crosbie J, Ouvrier RA:Development and validation of a novel ratingsystem for scoring standing foot posture: the FootPosture Index. Clinical Biomechanics. 2006; 21:89-98.
- Chuter VH: Relationships between foot type anddynamic rearfoot plane motion. Journal of Footand Ankle Research. 2010; 3:9.
- Kellgren JH, Lawrence JS. Radiologicalassessment of osteoarthritis. Ann Rheum Dis1957; 16: 494-501
- Lawrence RC, Helmick CG, Arnett FC, Deyo RA,Felson DT, Giannini EH, Heyse SP, Hirsch.Estimates of the prevalence of arthritis andselected musculoskeletal disorders in the UnitedStates. Arthritis and Rheumatism. 1998; 41: 778–99.
- Cooper C. Rheumatology. Epidemiology ofosteoarthritis. In (eds.) Klippel JH, Dieppe PA. 2nd edition. Mosby Publisher London; 1998:1–20.
- Cooper C, Snow S, Mcalindon TE, Kellingray S,Stuart B, Coggon D and Paul A. Risk Factors forthe incidence and progression of radiographicknee osteoarthritis. Arthritis and Rheumatism. 2000; 43(5): 995–1000.
- Riegger-Krugh C, Keysor JJ. Skeletalmalalignment of the lower quarter: correlated andcompensatory motions and postures. Journal ofOrthopedic and Sports Physical Therapy. 1996;23: 164-170.
- Bennell KL, Boeles KA, Payne C, Cicuttini F,Williamson E, Forbes A, Hanna F, Tuck MD,Hinman R. Lateral wedge shoes insoles formedial knee osteoarthritis: a 12-monthrandomized controlled trial. Journal of ankle andfoot research. 2011, 4(suppl 1): 07.
- Kuroyangi Y, Nagura T, Matsumoto H, Otani T,Suda Y, Nakamura T, Toyama Y. The lateralwedged insole with subtalar strappingsignificantly reduces dynamic knee load in themedial compartment. Osteoarthritis andCartilage. 2007; 15, 932-936.
- Genova JM, Gross MT. Effect of Foot Orthoticson Calcaneal Eversion during standing andtreadmill walking for subjects with abnormalpronation. Journal of Orthopaedic and SportsPhysical Therapy. 2000; 30 (11): 664-675.
- Nakajima K, Kakihana W, Nakagawa T, MitomiH, Hikita A, Suzuki R, Akai M, Iwaya T,Nakamura K, Fukui N. Addition of an archsupport improves the biomechanical effect of alaterally wedged insole. Journal of Gait andPosture. 2009; 29: 208-213.
- Redmond Anthony. The Foot Posture Index: Userguide and manual. 1998; 1-19. https://www.leeds.ac.uk.com, accessed on 05/08/2011.
- Reilly K, Barker K, Shamley D, Newman M,Oskrochi GR, Sandall S: The role of foot and ankleassessment of patients with lower limbosteoarthritis. Journal of Foot and AnkleResearch. 2009; 95: 164-169.
- Vulnerability of India for Sub Prime Housing Crisis
Abstract Views :407 |
PDF Views:100
Authors
Akhil Swami
1,
Sonia Singh
1
Affiliations
1 Amity Business School (Amity University, Noida), IN
1 Amity Business School (Amity University, Noida), IN
Source
Review of Professional Management- A Journal of New Delhi Institute of Management, Vol 6, No 2 (2008), Pagination: 21-23Abstract
No Abstract.Full Text
- Buccal Mucoadhesive Tablets of Metronidazole
Abstract Views :187 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmaceutics, S.N. Institute of Pharmacy, Pusad, Dist Yavatmal, M.S. 445216, IN
2 Sharad Pawar College of Pharmacy, Wandongari, Nagpur.(M.S.), IN
1 Department of Pharmaceutics, S.N. Institute of Pharmacy, Pusad, Dist Yavatmal, M.S. 445216, IN
2 Sharad Pawar College of Pharmacy, Wandongari, Nagpur.(M.S.), IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 5, No 5 (2013), Pagination: 282-287Abstract
The present study aims at designing and evaluating a buccal mucoadhesive tablet of Metronidazole using mucoadhesive polymers like HPMC, Sodium CMC, Carbopol 934, Ethyl cellulose. Both Non aqueous granulation and direct compression methods were studied. Various evaluation parameters such as swelling index, ex-vivo mucoadhesive strength, in-vitro drug release, drug content and in-vitro dissolution parameters were studied for the formulation. Formulation MT07 with HPMC, Carbopol and ethyl cellulose was found to have good mucoadhesive strength, an in-vitro release of 7 hrs and good swelling index and other evaluation parameters. The drug release mechanism was found to be controlled by diffusion mechanism and follows zero order dissolution pattern. No drug - excipient interaction was seen in FTIR spectrum The formulation MT07 can be effectively used as buccal mucoadhesive tablet, to reduce the metronidazole dose and its adverse effects.Keywords
Mucoadhesive Buccal Tablet, Metronidazole, HPMC, Sodium Carboxy Methyl Cellulose, Carbopol 934, Ethyl Cellulose.- HR Practices for Attracting and Retaining Talent in it Organizations in Bangalore:The Employee Perspective
Abstract Views :163 |
PDF Views:0
Authors
Affiliations
1 Department of Business Administration, Sambalpur University, Odisha, IN
1 Department of Business Administration, Sambalpur University, Odisha, IN
Source
Asian Journal of Management, Vol 8, No 3 (2017), Pagination: 865-872Abstract
Any organization desires to have highly skilled and potential people on rolls who can become the competitive advantage for the company. Engaging such people requires a lot of motivation in terms of work, workplace culture, supervisors and of course compensation. There are many HR practices that an organization implements to engage people because engagement leads to productivity. The only way HR dept can sustain the competitive advantage is by continuously reinventing the fundamentals of people management. This paper is a part of a larger study on HR Practices and its relationship with employee retention. It attempts to explore the employees’ perspective of HR practices in the organization. The objective of this research paper is to understand what employees think about organizational practices. In order to carry out the study Focus group discussions were conducted with thirty IT employees of different levels in Bangalore. Analysis of responses is done using the software Nvivo10. Themes have been drawn and discussed in detail. It emphasizes the need for organizations to adapt employee friendly practices to attract and retain the top talent.Keywords
Compensation, Flexibility, HR Practices, Managers, Retention.References
- Analoui, F. (2002) The changing patterns of HRM pp. 30, Ashgate, UK
- Bagshaw M (2004) “Is diversity divisive? A positive training approach”, Industrial and Commercial Training 36, 4, 153-157
- Becker, B.E., Huselid, M.A., and Ulrich, D. 2001. The HR scorecard: Linking people, strategy, and performance. Boston, MA: Harvard Business School Press
- Gill, Carol (2007) A review of the critical perspective of Human resource management, Melbourne Business School.
- Gratton L, Hope-Hailey V, Stiles P and Truss C (1999) Strategic Human Resource Management. New York: Oxford University Press, 40-58
- Khatri N., (1999),”Emerging issues in Strategic HRM IN Singapore “, International Journal of Manpower, Vol. 20, No.8, pp. 516-529.
- Rundle, S.J.(1997), “Flexibility , adaptiveness and responsiveness (FAR-ness) as the key success factors in market entry in the south east Asian growth wedge “, PhD thesis, Department of Management, Monash University, Victoria.
- Schuler, R.S. and Jackson, S.E. (1987) “Linking competitive strategies with human resource management practices”, Academy of Management Executive, Vol. 1, No.3,pp. 207-19.
- Schuler Randall S. and MacMillan Ian C. (1984), “Gaining Competitive Advantage through Human Resource Management Practices”, Human Resource Management, Fall 1984, Vol. 23, No. 3, pp. 241-25
- Storey, J. (ed.) (1995). ‘Human Resource Management: A Critical Text’. London: Routledge
- Wright P and McMahan G (1992) Theoretical perspectives for strategic management, Journal of Management 18(2): 295-320
- A Compressive Review on Novel Molecular Target of Diabetic Nephropathy
Abstract Views :89 |
PDF Views:0
Authors
Affiliations
1 Institute of Pharmaceutical Research, GLA University, 17 KM Stone, NH#2, Mathura - Delhi Road, P.O.: Chaumuhan Mathura – 281406,, IN
1 Institute of Pharmaceutical Research, GLA University, 17 KM Stone, NH#2, Mathura - Delhi Road, P.O.: Chaumuhan Mathura – 281406,, IN
Source
Research Journal of Pharmacy and Technology, Vol 15, No 3 (2022), Pagination: 1398-1404Abstract
Diabetic nephropathy (DN) is a leading cause of mortality and morbidity, decreases quality of life and shortened life expectancy. The renin angiotensin system is considered to be involved in most of the pathological processes that result in diabetic nephropathy. Various subsystems of RAAS contribute to the disease pathology. One of these involves angiotensin II (Ang II) which shows increased activity during diabetic nephropathy. Evidence indicates interaction between advanced glycation end products (AGEs), activated protein kinase C (PKC) and angiotensin II provoke the progression of DN. Inhibitors of angiotensin-converting enzyme (ACEIs), renin angiotensin aldosterone system (RAAS), AGEs, and PKC have been tested for slowing down the progression of DN. This review focuses on the latest published data dealing with the pathophysiology, stages of DN, pathogenesis, prevention and treatment of DN.Keywords
Diabetic Nephropathy, Angiotensin, Nitric Oxide, Polyol Pathway, PKc.References
- Ugochukwu NH, Babady NE, Cobourne M, et al. The effect of Gongronema latifolium extracts on serum lipid profile and oxidative stress in hepatocytes of diabetic rats. Journal of biosciences. 2003 Feb 1; 28(1):1-5.
- Owu DU, Antai AB, Udofia KH, et al. Vitamin C improves basal metabolic rate and lipid profile in alloxan-induced diabetes mellitus in rat. J. Biosciences. 2006; 31: 575-579
- Ahmed N. Alloxan diabetes-induced oxidative stress and impairment of oxidative defense system in rat brain: neuroprotective effects of cichorium intybus. Int J Diabetes & Metabolism. 2009; 17:105-9.
- Soetikno V, Arozal W, Louisa M, et al. New insight into the molecular drug target of diabetic nephropathy. International journal of endocrinology. 2014; 2014.
- Onozato ML, Tojo A. Role of NADPH oxidase in hypertension and diabetic nephropathy. Current Hypertension Reviews. 2005 Jan 1; 1(1):15-20.
- Pan Y, Wang Y, Cai L, et al. Inhibition of high glucose‐induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats. British journal of pharmacology. 2012 Jun; 166(3):1169-82.
- Satirapoj B. Nephropathy in diabetes. In Diabetes 2013 (pp. 107-122). Springer, New York, NY.
- Gnudi L, Viberti G, Raij L, et al. GLUT-1 over expression: link between hemodynamic and metabolic factors in glomerular injury? Hypertension. 2003 Jul 1; 42(1):19-24.
- Singh N, Sharma P, Garg V, et al. Antioxidant therapy in diabetic nephropathy. Journal of Pharmacy Research. 2011 Nov; 4(11):4249-51.
- Gnudi L. Cellular and molecular mechanisms of diabetic glomerulopathy. Nephrology Dialysis Transplantation. 2012 Jul 1; 27(7):2642-9.
- Ha H, Hwang IA, Park JH, et al. Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes research and clinical practice. 2008 Nov 13; 82:S42-5.
- Tavafi M. Diabetic nephropathy and antioxidants. Journal of nephropathology. 2013 Jan; 2(1):20.
- Arya A, Yadav HN, Sharma PL. Involvement of vascular endothelial nitric oxide synthase in development of experimental diabetic nephropathy in rats. Molecular and cellular biochemistry. 2011 Aug 1; 354(1-2):57-66.
- Dellamea BS, Leitão CB, Friedman R, et al. Nitric oxide system and diabetic nephropathy. Diabetology & metabolic syndrome. 2014 Dec 1; 6(1):17.
- Hilgers KF, Veelken R. Type 2 diabetic nephropathy: never too early to treat? J Am Soc Nephrol. 2002; 16(3):574-75.
- Rüster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. Journal of the American Society of Nephrology. 2006 Nov 1; 17(11):2985-91.
- El-Asrar AM. Role of inflammation in the pathogenesis of diabetic retinopathy. Middle East African journal of ophthalmology. 2012 Jan; 19(1):70.
- Bonnet F, Candido R, Carey RM, et al. Renal expression of angiotensin receptors in long-term diabetes and the effects of angiotensin type 1 receptor blockade. Journal of hypertension. 2002 Aug 1; 20(8):1615-24.
- Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circulation research. 2010 Apr 30; 106(8):1319-31.
- El-Asrar AM. Role of inflammation in the pathogenesis of diabetic retinopathy. Middle East African journal of ophthalmology. 2012 Jan; 19(1):70.
- Song J, Eyster KM, Kost Jr CK, et al. Involvement of protein kinase C-CPI-17 in androgen modulation of angiotensin II-renal vasoconstriction. Cardiovascular research. 2010 Feb 1; 85(3):614-21.
- Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circulation research. 2010 Apr 30; 106(8):1319-31.
- Peng F, Wu D, Gao B, Ingram AJ, Zhang B, Chorneyko K, McKenzie R, Krepinsky JC. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes. 2008 Jun 1; 57(6):1683-92.
- Bach LA. Rho kinase inhibition: a new approach for treating diabetic nephropathy?. Diabetes. 2008 Mar 1; 57(3):532-33.
- Kolavennu V, Zeng L, Peng H, et al. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes. 2008 Mar 1; 57(3):714-23.
- Peng F, Wu D, Gao B, et al. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes. 2008 Jun 1; 57(6):1683-92.
- Suryavanshi SV, & Kulkarni Y A. NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes. Frontiers in pharmacology. 2017 8: 798.
- Ahmed S, Mundhe N, Borgohain M. et al. Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy. Inflammation. 2016 39, 1783–1797. https://doi.org/10.1007/s10753-016-0413-4
- Navarro-Gonzalez JF, Mora-Fernández C, De Fuentes MM, García-Pérez, J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat. Rev. Nephrol. 2011, 7, 327–340.
- Luo C, Yang H, Tang C, et al. Kaempferol alleviates insulin resistance via hepatic IKK/NF-KB signal in type 2 diabetic rats. Int Immunopharmacol 2015; 28:744–50.
- Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal transduction and targeted therapy. 2017 2, 17023.
- Muhonen P, Holthofer H. Epigenetic and microRNA mediated regulation in diabetes. Nephrol Dial Transplant 2009; 24:1088–96
- Moura J, Børsheim E, Carvalho E. The role of MicroRNAs in diabetic complications—special emphasis on wound healing. Genes 2014; 5:926–56.
- McClelland AD, Herman-Edelstein M, Komers R, et al. MiR- 21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. Clin Sci 2015; 129:1237–49.
- Zhang Z, Peng H, Chen J, et al. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett 2009; 583.
- Wang Q, Wang Y, Minto AW, et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 2008;22: 4126–35.
- Long J, Wang Y, Wang W, Chang BH, Danesh FR. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem 2010; 285:23457–65.
- Wahlquist C, Jeong D, Rojas-Mun˜ oz A, et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature 2014; 508:531–538
- Dey N, Das F, Mariappan MM, et al. MicroRNA-21 orchestrates high glucose-induced signals to TOR complex1, resulting in renal cell pathology in diabetes. J Biol Chem 2011; 286:25586–603. 40. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nature Reviews Genetics. 2012 Jul;13(7):484-92.
- Barrès R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, Krook A, Zierath JR. Non-CpG methylation of the PGC-1α promoter through DNMT3B controls mitochondrial density. Cell metabolism. 2009 Sep 2;10(3):189-98.
- Tonna S, El-Osta A, Cooper ME, Tikellis C. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms. Nature Reviews Nephrology. 2010 Jun; 6(6):332-41.
- Vivian EM, Rubinstein GB. Pharmacologic management of diabetic nephropathy. Clinical therapeutics. 2002 Nov 1; 24(11):1741-56.
- Ravid M, Neumann L, Lishner M. Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors. Kidney international. 1995 Mar 1; 47(3):907-10.
- De P, Das G, Harley K, et al. Dual blockade of renin-angiotensin system in diabetic nephropathy: review of literature and local experience. The British Journal of Diabetes & Vascular Disease. 2006 Jan; 6(1):23-8.
- Gan Z, Huang D, Jiang J, et al. Captopril alleviates hypertension-induced renal damage, inflammation, and NF-κB activation. Brazilian Journal of Medical and Biological Research. 2018; 51(11).
- Mazerska M, Myśliwiec M. Telmisartan lowers albuminuria in type 2 diabetic patients treated with angiotensin enzyme inhibitors. Advances in Medical Sciences (De Gruyter Open). 2009 Jun 1; 54(1).
- Shakya R, Goyal A, Semwal BC, et al. Role of Brain Angiotensin (1-7) In Chronic Hyperglycaemia Induced Nephropathy in Wistar Rats. Indian journal of Pharmaceutical education & Research. 2017 Jan 1; 51(1):83-91.
- Simes BC, MacGregor GG. Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide. Diabetes, metabolic syndrome and obesity: targets and therapy. 2019; 12:2125.
- Milder TY, Stocker SL, Abdel Shaheed C, et al. Combination therapy with an SGLT2 inhibitor as initial treatment for type 2 diabetes: a systematic review and meta-analysis. Journal of clinical medicine. 2019 Jan; 8(1):45.
- Cefalu WT, Leiter LA, Yoon KH, et al. Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52-week results from a randomised, double-blind, phase 3 non-inferiority trial. The Lancet. 2013 Sep 14; 382(9896):941-50.
- Zhang Z, Sun L, Wang Y, et al. Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney international. 2008 Jan 2; 73(2):163-71.
- Li YC. Vitamin D and diabetic nephropathy. Current diabetes reports. 2008 Dec 1; 8(6):464-9.
- Bakris GL, Weir MR, Dequattro V, et al. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney international. 1998 Oct 1; 54(4):1283-9.
- Schjoedt KJ, Rossing K, Juhl TR, et al. Beneficial impact of spironolactone in diabetic nephropathy. Kidney international. 2005 Dec 1; 68(6):2829-36.
- Forbes JM, Thallas V, Thomas MC, et al. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. The FASEB Journal. 2003 Sep; 17(12):1762-4.
- Kelly DJ, Zhang Y, Hepper C, et al. Protein kinase C β inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension. Diabetes. 2003 Feb 1; 52(2):512-8.
- Ko GJ, Kang YS, Han SY, et al. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. Nephrology Dialysis Transplantation. 2008 Sep 1; 23(9):2750-60.
- Ohga S, Shikata K, Yozai K, et al. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti- inflammatory effects mediated by inhibition of NF-κB activation. American Journal of Physiology-Renal Physiology. 2007 Apr; 292(4):F1141-50.
- De Galan, B.E., Zoungas, S., Chalmers, J, et al. 2009. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia, 52(11), pp.2328-2336.
- Bakris GL, Copley JB, Vicknair N, et al. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney international. 1996 Nov 1; 50(5):1641-50.
- Bakris GL, Barnhill BW, Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney international. 1992 Apr 1; 41(4):912-9.
- Hovind P, Rossing P, Tarnow L, et al. Remission of nephrotic-range albuminuria in type 1 diabetic patients. Diabetes Care. 2001 Nov 1; 24(11):1972-7.
- Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nature Reviews Genetics. 2012 Jul; 13(7):484-92.
- Barrès R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, Krook A, Zierath JR. Non-CpG methylation of the PGC-1α promoter through DNMT3B controls mitochondrial density. Cell metabolism. 2009 Sep 2; 10(3):189-98.
- Gray SG, De Meyts P. Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes/Metab Res Rev 2005; 21:416–33